Literature DB >> 16578971

[Case of dermatomyositis complicated with massive pleural effusion that preceded the myopathy].

Hideyuki Iwai1, Ryuji Koike, Jun Ogawa, Takahiko Sugihara, Hiroyuki Hagiyama, Kenji Nagasaka, Yoshinori Nonomura, Junko Nishio, Toshihiro Nanki, Rieko Tsubata, Hitoshi Kohsaka, Tetsuo Kubota, Nobuyuki Miyasaka.   

Abstract

A 36-year-old man was admitted to a hospital with complaints of fever, polyarthralgia and dyspnea. Erythema was observed on his face, extensor surface of the fingers and extremities, and a chest X-ray revealed massive bilateral pleural effusion. He had no sign of myopathy at this point. Pleural fluid was proved to be exudative and contained extremely high levels of hyaluronic acid. He was also complicated with interstitial pneumonitis and was given a pulse therapy with methyl prednisolone followed by daily administration of 55 mg prednisolone (PSL). Twenty days after the commencement of the therapy, pleural effusion decreased but muscle weakness gradually appeared, accompanied by elevation of myogenic enzymes. Myogenic changes on electromyogram, and irregularity of the muscle fibers with slight inflammatory cell infiltrates in a biopsy specimen were demonstrated. He was transferred to our hospital, and a diagnosis of dermatomyositis was made. Later, pleural effusion waxed and waned depending on the dosage of PSL, but no other causative disorder was demonstrated by extensive examinations. This case indicates that the pleuritis could be one of the vasculitic manifestations of dermatomyositis.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 16578971     DOI: 10.2177/jsci.25.270

Source DB:  PubMed          Journal:  Nihon Rinsho Meneki Gakkai Kaishi        ISSN: 0911-4300


  1 in total

1.  Anti-PL-7 Antisynthetase Syndrome with Eosinophilic Pleural Effusion.

Authors:  Go Saito; Masato Kono; Akari Tsutsumi; Yu Koyanagi; Koichi Miyashita; Takeshi Kobayashi; Hironao Hozumi; Yoshihiro Miki; Yoshifumi Arai; Yoshiro Otsuki; Dai Hashimoto; Tomoyuki Fujisawa; Toru Nakamura; Takafumi Suda; Hidenori Nakamura
Journal:  Intern Med       Date:  2018-03-09       Impact factor: 1.271

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.